Literature DB >> 28612347

Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis.

Hui Liu1, Jie Yao1, Weijing Wang1, Dongfeng Zhang1.   

Abstract

A meta-analysis was conducted to evaluate the association between duration of oral contraceptive use and risk of hypertension. Relevant studies published in English or Chinese were identified by a search of PubMed, Web of Science, Wanfang Database, and China National Knowledge Infrastructure to January 2017. Seventeen articles containing 24 studies with 270,284 participants were included in this meta-analysis. The pooled relative risk of hypertension for the highest vs lowest category of oral contraceptive duration was 1.47 (95% confidence interval, 1.25-1.73), and excluding three studies with a relative risk >3.0 yielded a pooled relative risk of 1.26 (95% confidence interval, 1.11-1.44). A linear dose-response relationship was found (Pnonlinearity =0.69) and the risk of hypertension increased by 13% (relative risk, 1.13; 95% confidence interval, 1.03-1.25) for every 5-year increment in oral contraceptive use. The duration of oral contraceptive use was positively associated with the risk of hypertension in this meta-analysis. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  hypertension; meta-analysis; oral contraceptive use

Mesh:

Substances:

Year:  2017        PMID: 28612347      PMCID: PMC8030990          DOI: 10.1111/jch.13042

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  44 in total

1.  Use of oral contraceptives in Germany: prevalence, determinants and use-associated health correlates. Results of National Health Surveys from 1984 to 1999.

Authors:  Yong Du; Hans-Ulrich Melchert; Monika Schäfer-Korting
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2007-02-21       Impact factor: 2.435

Review 2.  Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.

Authors:  Jennifer M Gierisch; Remy R Coeytaux; Rachel Peragallo Urrutia; Laura J Havrilesky; Patricia G Moorman; William J Lowery; Michaela Dinan; Amanda J McBroom; Vic Hasselblad; Gillian D Sanders; Evan R Myers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-06       Impact factor: 4.254

3.  Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg).

Authors:  Rogério Bonassi Machado; Paula Fabrini; Achilles Machado Cruz; Edna Maia; Alvaro da Cunha Bastos
Journal:  Contraception       Date:  2004-11       Impact factor: 3.375

4.  Prevalence and risk factors for prehypertension and hypertension in five Indian cities.

Authors:  Ram B Singh; Jan Fedacko; Daniel Pella; Zelmira Macejova; Saraswati Ghosh; K de Amit; Raheena Begom; Zubeda A Tumbis; Memuna Haque; Shaillendra K Vajpeyee; Fabien de Meester; Chibisov Sergey; Radzhesh Agarwalo; Veerappan V Muthusamy; Alok K Gupta
Journal:  Acta Cardiol       Date:  2011-02       Impact factor: 1.718

5.  Prospective study of oral contraceptives and hypertension among women in the United States.

Authors:  L Chasan-Taber; W C Willett; J E Manson; D Spiegelman; D J Hunter; G Curhan; G A Colditz; M J Stampfer
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

Review 6.  Hypertension, genotype and oral contraceptives.

Authors:  Paolo Mulatero; Stefania Morra di Cella; Franco Veglio
Journal:  Pharmacogenomics       Date:  2002-01       Impact factor: 2.533

7.  Myocardial infarction in users of low-dose oral contraceptives.

Authors:  S Sidney; D B Petitti; C P Quesenberry; A L Klatsky; H K Ziel; S Wolf
Journal:  Obstet Gynecol       Date:  1996-12       Impact factor: 7.661

8.  Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression.

Authors:  Lawrence A Olatunji; Young-Mi Seok; Adedoyin Igunnu; Seol-Hee Kang; In-Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-22       Impact factor: 3.000

9.  Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.

Authors:  Can Yucel Karabay; Gonenc Kocabay; Vecih Oduncu; Arzu Kalayci; Ahmet Guler; Ali Karagöz; Ozkan Candan; Ozcan Basaran; Regayip Zehir; Akın Izgi; Ali Metin Esen; Cevat Kırma
Journal:  Catheter Cardiovasc Interv       Date:  2013-03-02       Impact factor: 2.692

10.  Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis.

Authors:  Hui Liu; Jie Yao; Weijing Wang; Dongfeng Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-13       Impact factor: 3.738

View more
  17 in total

Review 1.  Hypertension in Premenopausal and Postmenopausal Women.

Authors:  Yasmin Brahmbhatt; Maitreyee Gupta; Seyed Hamrahian
Journal:  Curr Hypertens Rep       Date:  2019-08-26       Impact factor: 5.369

2.  Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.

Authors:  Mildren A Del-Sueldo; María A Mendonça-Rivera; Martha B Sánchez-Zambrano; Judith Zilberman; Ana G Múnera-Echeverri; María Paniagua; Lourdes Campos-Alcántara; Claudia Almonte; Amalia Paix-Gonzales; Claudia V Anchique-Santos; Claudine J Coronel; Gabriela Castillo; María G Parra-Machuca; Ivanna Duro; Paola Varletta; Patricia Delgado; Verónica I Volberg; Adriana C Puente-Barragán; Adriana Rodríguez; Aida Rotta-Rotta; Anabela Fernández; Ana C Izeta-Gutiérrez; Ana E Ancona-Vadillo; Analía Aquieri; Andrea Corrales; Andrea Simeone; Bibiana Rubilar; Carolina Artucio; Carolina Pimentel-Fernández; Celi Marques-Santos; Clara Saldarriaga; Christian Chávez; Cristina Cáceres; Dahiana Ibarrola; Daniela Barranco; Edison Muñoz-Ortiz; Edith D Ruiz-Gastelum; Eduardo Bianco; Elena Murguía; Enrique Soto; Fabiola Rodríguez-Caballero; Fanny Otiniano-Costa; Giovanna Valentino; Iris B Rodríguez-Cermeño; Ivan R Rivera; Jairo A Gándara-Ricardo; Jesús A Velásquez-Penagos; Judith Torales; Karina Scavenius; Karen Dueñas-Criado; Laura García; Laura Roballo; Lucía R Kazelian; Macarena Coussirat-Liendo; María C Costa-Almeida; Mariana Drever; Mariela Lujambio; Marildes L Castro; Maritza Rodríguez-Sifuentes; Mónica Acevedo; Mónica Giambruno; Mónica Ramírez; Nancy Gómez; Narcisa Gutiérrez-Castillo; Onelia Greatty; Paola Harwicz; Patricia Notaro; Rocío Falcón; Rosario López; Sady Montefilpo; Sara Ramírez-Flores; Silvina Verdugo; Soledad Murguía; Sonia Constantini; Thais C Vieira; Virginia Michelis; César M Serra
Journal:  Arch Cardiol Mex       Date:  2022

3.  Effect of oral hormonal contraceptive pill use on the hemodynamic response to the cold pressor test.

Authors:  Dain W Jacob; Aaron M Voshage; Jennifer L Harper; Jacqueline K Limberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-04-29       Impact factor: 5.125

4.  Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis.

Authors:  Hui Liu; Jie Yao; Weijing Wang; Dongfeng Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-13       Impact factor: 3.738

5.  Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.

Authors:  Duru Shah; Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun

6.  Oral Contraceptive Use and Increased Risk of Stroke: A Dose-Response Meta-Analysis of Observational Studies.

Authors:  Feng Li; Lin Zhu; Jie Zhang; Hongye He; Yueqi Qin; Yuan Cheng; Zongyi Xie
Journal:  Front Neurol       Date:  2019-09-23       Impact factor: 4.003

7.  Hypertension in a patient with medullary sponge kidney: A case report.

Authors:  Fengyuan Wu; Ying Zhang; Yunpeng Cheng; Yan Lu; Yinong Jiang; Wei Song
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

8.  Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis, methodological and statistical issues.

Authors:  Samaneh Asgari
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

9.  Response to: Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis: Methodological and statistical issues.

Authors:  Hui Liu; Dongfeng Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

10.  Demographic, socioeconomic, and biological correlates of hypertension in an adult population: evidence from the Bangladesh demographic and health survey 2017-18.

Authors:  Afrin Iqbal; Karar Zunaid Ahsan; Kanta Jamil; M Moinuddin Haider; Shusmita Hossain Khan; Nitai Chakraborty; Peter Kim Streatfield
Journal:  BMC Public Health       Date:  2021-06-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.